Malesci was the first Italian company to provide the doctor with preparations for asthma therapy and all pathologies of a broncho-constrictive nature, and has long been directly involved in research trends relating to the respiratory and cardiological apparatus.

In recent years, Malesci has financed research projects of notable scientific interest, concentrated above all in the asthmatic-inflammation, cardiovascular and antitumour sectors.

Malesci is currently investing considerable resources, in projects aimed at neurokinin antagonist synthesis (anti-inflammatory activity), and ligands in the Fas system (antitumour), by taking part in research co-ordinated by the laboratories of the Menarini Group.

Furthermore, Malesci is committed to research and development activities in collaboration with prestigious universities, hospitals and clinical research institutions.